Literature DB >> 30259311

Risk factors for atrophic gastritis in the Japanese young and middle-aged: a study using double-contrast upper gastrointestinal barium X-ray radiography.

Kimihiko Endo1, Hiroshi Nakada2, Yoshihito Kadota2, Youichi Mizutani2, Norihiro Shinkawa2, Koji Onoe3, Naoki Yoshinaga4, Minako Azuma2, Toshinori Hirai2.   

Abstract

PURPOSE: To identify risk factors for atrophic gastritis in Japanese young and middle-age subjects by double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR).
MATERIALS AND METHODS: We included 351 consecutive Japanese subjects (158 males, 193 females; age 25-49 years, mean 44 years) seen between October 2014 and March 2016. All underwent serum Helicobacter pylori (Hp) antibody- and UGI-XR examinations. Two radiologists independently recorded their UGI-XR findings of atrophic gastritis (AG). Interobserver agreement was assessed by calculating the kappa (κ) coefficient. Univariate and multivariate analyses were performed to investigate the association between AG and the subjects' gender, smoking habit, alcohol intake, body mass index, and Hp infection.
RESULTS: AG was diagnosed in 85 subjects (24%) on UGI-XR images; interobserver agreement was good (κ = 0.745). By univariate analysis, the male gender and a high serum Hp titer (IgG ≥ 10 U/ml) were significantly association with AG (p < 0.05). Multivariate analysis revealed that a high serum Hp titer was the only independent, significant factor (p < 0.05). The odds ratio for a high serum Hp titer was 128 (95% CI, 54.8-498.4).
CONCLUSION: Our UGI-XR study indicated that Hp infection was significantly associated with AG in Japanese young and middle-aged subjects.

Entities:  

Keywords:  Atrophic; Gastritis; Helicobacter pylori; Risk Factors; X-Rays

Mesh:

Substances:

Year:  2018        PMID: 30259311     DOI: 10.1007/s11604-018-0782-8

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  26 in total

1.  Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

Authors:  E C Klinkenberg-Knol; F Nelis; J Dent; P Snel; B Mitchell; P Prichard; D Lloyd; N Havu; M H Frame; J Romàn; A Walan
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

Review 2.  Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.

Authors:  Parisa Karimi; Farhad Islami; Sharmila Anandasabapathy; Neal D Freedman; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.254

3.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.

Authors:  H Watabe; T Mitsushima; Y Yamaji; M Okamoto; R Wada; T Kokubo; H Doi; H Yoshida; T Kawabe; M Omata
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 4.  Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies.

Authors:  Mariam Abdullahi Adamu; Melanie Nicole Weck; Lei Gao; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2010-06-29       Impact factor: 8.082

5.  Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis.

Authors:  Shigeto Mizuno; Ikuya Miki; Tsukasa Ishida; Masaru Yoshida; Mitsuko Onoyama; Takeshi Azuma; Yasuki Habu; Hideto Inokuchi; Kotaro Ozasa; Kazumasa Miki; Yoshiyuki Watanabe
Journal:  Dig Dis Sci       Date:  2010-03-04       Impact factor: 3.199

6.  Fatty and lean red meat consumption in China: differential association with Chinese abdominal obesity.

Authors:  Z Wang; B Zhang; F Zhai; H Wang; J Zhang; W Du; C Su; J Zhang; H Jiang; B M Popkin
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-03-20       Impact factor: 4.222

7.  Atrophic gastritis, but not antibody to Helicobacter pylori, is associated with body mass index in a Japanese population.

Authors:  Takehiro Torisu; Takayuki Matsumoto; Yutaka Takata; Toshihiro Ansai; Inho Soh; Shuji Awano; Ikuo Nakamichi; Shuntaro Kagiyama; Kazuo Sonoki; Akihiro Yoshida; Tomoko Hamasaki; Mitsuo Iida; Tadamichi Takehara
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

8.  Comparative analysis of upper gastrointestinal endoscopy, double-contrast upper gastrointestinal barium X-ray radiography, and the titer of serum anti-Helicobacter pylori IgG focusing on the diagnosis of atrophic gastritis.

Authors:  Nobutake Yamamichi; Chigaya Hirano; Yu Takahashi; Chihiro Minatsuki; Chiemi Nakayama; Rie Matsuda; Takeshi Shimamoto; Chihiro Takeuchi; Shinya Kodashima; Satoshi Ono; Yosuke Tsuji; Mitsuhiro Fujishiro; Ryoichi Wada; Toru Mitsushima; Kazuhiko Koike
Journal:  Gastric Cancer       Date:  2015-07-30       Impact factor: 7.370

9.  Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial.

Authors:  L Lundell; N Havu; P Miettinen; H E Myrvold; L Wallin; R Julkunen; K Levander; J G Hatlebakk; B Liedman; M Lamm; A Malm; A Walan
Journal:  Aliment Pharmacol Ther       Date:  2006-03-01       Impact factor: 8.171

10.  Associated factors of atrophic gastritis diagnosed by double-contrast upper gastrointestinal barium X-ray radiography: a cross-sectional study analyzing 6,901 healthy subjects in Japan.

Authors:  Nobutake Yamamichi; Chigaya Hirano; Takeshi Shimamoto; Chihiro Minatsuki; Yu Takahashi; Chiemi Nakayama; Rie Matsuda; Mitsuhiro Fujishiro; Maki Konno-Shimizu; Jun Kato; Shinya Kodashima; Satoshi Ono; Keiko Niimi; Satoshi Mochizuki; Yosuke Tsuji; Yoshiki Sakaguchi; Itsuko Asada-Hirayama; Chihiro Takeuchi; Seiichi Yakabi; Hikaru Kakimoto; Ryoichi Wada; Toru Mitsushima; Masao Ichinose; Kazuhiko Koike
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

View more
  1 in total

1.  Association of dietary patterns and endoscopic gastric mucosal atrophy in an adult Chinese population.

Authors:  Song Lin; Tao Gao; Chongxiu Sun; Mengru Jia; Chengxia Liu; Xingbin Ma; Aiguo Ma
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.